Literature DB >> 19187073

von Willebrand factor is a major determinant of ADAMTS-13 decrease during mouse sepsis induced by cecum ligation and puncture.

N Lerolle1, C Dunois-Lardé, I Badirou, D G Motto, G Hill, P Bruneval, J-L Diehl, C V Denis, D Baruch.   

Abstract

SUMMARY
BACKGROUND: During sepsis, von Willebrand factor (VWF) is abundantly secreted; the main mechanism regulating its size involves specific proteolysis by the metalloprotease ADAMTS-13.
OBJECTIVES: To determine whether ADAMTS-13 consumption due to its binding to, and/or cleavage, of VWF contributes to its decrease during sepsis and whether abrogating or enhancing ADAMTS-13 activity influences sepsis outcome.
METHODS: ADAMTS-13 activity was evaluated in a model of sepsis induced by cecum ligature and puncture (CLP) in wild-type and Vwf(-/-) mice. Sepsis outcome was studied in those mice and in Adamts-13(-/-) mice. Finally, survival was studied in wild-type mice injected hydrodynamically with the human ADAMTS-13 gene.
RESULTS: In wild-type mice, CLP-induced sepsis elicited a significant ADAMTS-13 decrease, and a strong negative correlation existed between VWF and ADAMTS-13. In Vwf(-/-) mice, CLP also induced severe sepsis, but ADAMTS-13 was not significantly diminished. Notably, Vwf(-/-) mice lived significantly longer than wild-type mice. In contrast, Adamts-13(-/-) mice and wild-type mice were comparable with regard to thrombocytopenia, VWF concentrations, absence of thrombi, and survival. Hydrodynamic hADAMTS-13 gene transfer with the pLIVE expression vector resulted in high and stable ADAMTS13 activity in CLP mice; however, no impact on survival was observed.
CONCLUSIONS: VWF secretion is a major determinant of ADAMTS-13 decrease in the CLP model, and plays an important role in sepsis-induced mortality, but the complete absence of its regulating protease, ADAMTS-13, had no detectable impact in this sepsis model. Furthermore, increasing ADAMTS-13 activity had no impact on survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19187073     DOI: 10.1111/j.1538-7836.2009.03313.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  15 in total

1.  Relevant role of von Willebrand factor in neutrophil recruitment in a mouse sepsis model involving cecal ligation and puncture.

Authors:  Shogo Kasuda; Hideto Matsui; Shiro Ono; Yasunori Matsunari; Kenji Nishio; Midori Shima; Katsuhiko Hatake; Mitsuhiko Sugimoto
Journal:  Haematologica       Date:  2015-10-22       Impact factor: 9.941

2.  Polymicrobial sepsis and endotoxemia promote microvascular thrombosis via distinct mechanisms.

Authors:  K N Patel; S H Soubra; F W Lam; M A Rodriguez; R E Rumbaut
Journal:  J Thromb Haemost       Date:  2010-03-12       Impact factor: 5.824

3.  ADAMTS-13 regulates neutrophil recruitment in a mouse model of invasive pulmonary aspergillosis.

Authors:  Astrid Alflen; Steve Prüfer; Katharina Ebner; Sebastian Reuter; Pamela Aranda Lopez; Inge Scharrer; Fumiaki Banno; Michael Stassen; Hansjörg Schild; Kerstin Jurk; Markus Bosmann; Hendrik Beckert; Markus P Radsak
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

4.  Platelet glycoprotein Ib-IX as a regulator of systemic inflammation.

Authors:  Adam Corken; Susan Russell; Judith Dent; Steven R Post; Jerry Ware
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-06       Impact factor: 8.311

5.  Role for platelet glycoprotein Ib-IX and effects of its inhibition in endotoxemia-induced thrombosis, thrombocytopenia, and mortality.

Authors:  Hong Yin; Aleksandra Stojanovic-Terpo; Weidong Xu; Adam Corken; Alexander Zakharov; Feng Qian; Sasha Pavlovic; Aleksandar Krbanjevic; Alexander V Lyubimov; Zaijie J Wang; Jerry Ware; Xiaoping Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-09-19       Impact factor: 8.311

6.  Preserved Expression of mRNA Coding von Willebrand Factor-Cleaving Protease ADAMTS13 by Selenite and Activated Protein C.

Authors:  Michael L Ekaney; Clemens L Bockmeyer; Maik Sossdorf; Philipp A Reuken; Florian Conradi; Tobias Schuerholz; Markus F Blaess; Scott L Friedman; Wolfgang Lösche; Michael Bauer; Ralf A Claus
Journal:  Mol Med       Date:  2015-04-03       Impact factor: 6.354

Review 7.  The function of ADAMTS13 in thrombogenesis in vivo: insights from mutant mice.

Authors:  Fumiaki Banno; Anil K Chauhan; Toshiyuki Miyata
Journal:  Int J Hematol       Date:  2010-01-05       Impact factor: 2.490

8.  Plasma DNA is Elevated in Patients with Deep Vein Thrombosis.

Authors:  J A Diaz; T A Fuchs; T O Jackson; J A Kremer Hovinga; B Lämmle; P K Henke; D D Myers; D D Wagner; T W Wakefield
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2013-10-01

Review 9.  VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP.

Authors:  Michael Schwameis; Christian Schörgenhofer; Alice Assinger; Margarete M Steiner; Bernd Jilma
Journal:  Thromb Haemost       Date:  2014-12-11       Impact factor: 5.249

10.  The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation.

Authors:  Vincent Peigne; Elie Azoulay; Isaline Coquet; Eric Mariotte; Michael Darmon; Paulette Legendre; Nadir Adoui; Anne Marfaing-Koka; Martine Wolf; Benoit Schlemmer; Agnès Veyradier
Journal:  Crit Care       Date:  2013-11-18       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.